Global and United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Report & Forecast 2024-2031

Report ID: 1835178 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others
Segment by Application
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Qiagen NV
GE Healthcare
Agilent Technologies
F Hoffman La Roche
Foundation Medicine
Thermo Fisher Scientific Inc.
Leica Biosystems Nussloch GmBH
Pfizer

Frequently Asked Questions
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Oral Care

Oral Care market is segmented by region (country), players, by Type and by Application. Players,  ... Read More